Advanced Search

Technical Analysis for AZNCF - Astrazeneca Plc Ord

Grade Last Price % Change Price Change
grade A 99.0 1.20% 1.1750
AZNCF closed up 1.2 percent on Friday, February 21, 2020, on 2 percent of normal volume.
0 Watchers
Watchlist Portfolio

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Flat
Historical AZNCF trend table...
Date Alert Name Type % Chg
Bollinger Band Squeeze Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
Gapped Up Strength 0.00%
Bollinger Band Squeeze Range Contraction 1.20%
Narrow Range Bar Range Contraction 1.20%
Stochastic Reached Oversold Weakness 1.20%
Strong but Oversold Other 1.20%
Gapped Up Strength 1.20%
Oversold Stochastic Weakness 1.20%
Bollinger Band Squeeze Range Contraction 2.22%
Older signals for AZNCF ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Analyze My Stocks!
Configure default chart indicators
AZNCF Chart by TradingView
Basic chart:

Profile

AstraZeneca PLC discovers, develops, and commercializes prescription medicines for the treatment of oncology, cardiovascular and metabolic, respiratory, gastrointestinal, neuroscience, and infection diseases worldwide. Its marketed products include Arimidex, Casodex/Cosudex, Calquence, Faslodex, Imfinzi, Iressa, Lynparza, Nolvadex, Tagrisso, and Zoladex for oncology diseases; Atacand1/Atacand HCT/Atacand Plus, Brilinta/Brilique, Crestor2, Plendil, Seloken/Toprol-XL4, Tenormin5, and Zestril6 for cardiovascular diseases; and Bydureon, Byetta, Farxiga/Forxiga, Kombiglyze XR, Komboglyze, Onglyza, Qtern, Symlin, Xigduo, and Xigduo XR for metabolic diseases. The company's marketed products also comprise Accolate, Bevespi Aerosphere, Bricanyl Respules, Bricanyl Turbuhaler, Daliresp/Daxas, Duaklir Genuair, Eklira Genuair/Tudorza Pressair, Fasenra, Oxis Turbuhaler, Pulmicort Turbuhaler/Pulmicort Flexhaler, Pulmicort Respules, Symbicort pMDI, Symbicort Turbuhaler, and Tudorza Pressair for respiratory diseases; Fluenz FluMist/Tetra Quadrivalen and Synagis3 for infection diseases; Movantik/Moventig, Seroquel IR, Seroquel XR, and Vimovo4 for neuroscience diseases; and Losec/Prilosec and Nexium for gastrointestinal diseases. The company serves primary care and specialty care physicians through distributors and local representative offices. AstraZeneca PLC has a strategic partnership with Bicycle Therapeutics; and with Biothera Pharmaceuticals, Inc. to evaluate cancer related drugs, as well as has a collaboration agreement with Innate Pharma S.A. for oncology development. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC has clinical collaboration with Immunomedics, Inc. for the development of Imfinzi(R) and sacituzumab govitecan combination therapy, to include second-line metastatic non-small cell lung cancer. AstraZeneca PLC was founded in 1992 and is headquartered in Cambridge, the United Kingdom.
Chemistry Cancer Chemical Compounds Organic Compounds Neuroscience Metabolic Diseases Cardiovascular Diseases Chloroarenes Respiratory Diseases Bristol Myers Squibb Astrazeneca Gastrointestinal Diseases Oncology Diseases

Is AZNCF a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

Recent News

Date Title
Feb 14 AstraZeneca Stock Dives As Coronavirus Expected To Batter 2020 Results
Feb 14 Risks Remain, but Amarin Stock Is a Buy at Today’s Prices
Feb 14 AstraZeneca Warns of Coronavirus Impact and Profits Tumble. The Stock Is Falling.
Feb 14 AstraZeneca's (AZN) Q4 Earnings and Sales Miss Estimates
Feb 14 GLOBAL MARKETS-European stocks climb to record on hopes of limited coronavirus economic hit
Feb 2 A Trio of High-Yield Stocks for the Dividend Investor
Jan 30 Delco company tops Forbes list of best employers for diversity
Jan 30 Educational Lung Cancer Event Coming to The Villages to Raise Awareness of the State’s High Rate of Lung Cancer
Jan 30 INSIGHT-On eve of Brexit, Britain faces critical test to defend drug trial crown
Jan 28 Read This Before Selling AstraZeneca PLC (LON:AZN) Shares
See more AZNCF news...

Indicators

Indicator Value
52 Week High 102.5
52 Week Low 62.82
Average Volume 6,070
200-Day Moving Average 82.9945
50-Day Moving Average 96.4502
20-Day Moving Average 99.5289
10-Day Moving Average 98.5740
Average True Range 1.2329
ADX 15.11
+DI 48.3274
-DI 43.5715
Chandelier Exit (Long, 3 ATRs ) 97.8013
Chandelier Exit (Short, 3 ATRs ) 100.5487
Upper Bollinger Band 102.0018
Lower Bollinger Band 97.0560
Percent B (%b) 0.39
BandWidth 4.9692
MACD Line 0.4128
MACD Signal Line 0.8418
MACD Histogram -0.429
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 99.0000
Resistance 3 (R3) 99.0000 99.0000 99.0000
Resistance 2 (R2) 99.0000 99.0000 99.0000 99.0000
Resistance 1 (R1) 99.0000 99.0000 99.0000 99.0000 99.0000
Pivot Point 99.0000 99.0000 99.0000 99.0000 99.0000
Support 1 (S1) 99.0000 99.0000 99.0000 99.0000 99.0000
Support 2 (S2) 99.0000 99.0000 99.0000 99.0000
Support 3 (S3) 99.0000 99.0000 99.0000
Support 4 (S4) 99.0000